<DOC>
	<DOCNO>NCT02065011</DOCNO>
	<brief_summary>Primary Objective : To evaluate long-term safety tolerability UshStat® patient Usher syndrome type 1B Secondary Objective : To assess long-term safety biological activity UshStat®</brief_summary>
	<brief_title>A Study Determine Long-Term Safety , Tolerability Biological Activity UshStat® Patients With Usher Syndrome Type 1B</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Usher Syndromes</mesh_term>
	<criteria>Provide sign date write informed consent ( appropriate assent ) locally require authorization eg , Health Insurance Portability Accountability Act ( HIPAA ) . Must enrol Protocol TDU13600 Must receive subretinal injection UshStat® Did receive UshStat® part TDU13600 protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>